末期腎不全（ESRD）治療薬の世界市場レポート（2023年）

レポートナンバー　0000035692

末期腎不全（ESRD）治療薬の世界市場レポート（2023年）

The Business Research Company

End Stage Renal Disease (ESRD) Drug Global Market Report 2023

発刊日 2023/05/16

言語英語

体裁PDF/250ページ

ライセンス/価格250ページ

0000035692

Single	5,000USD
Site	7,500USD
Enterprise	10,000USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

本レポートは、末期腎不全（ESRD）治療薬の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている末期腎不全（ESRD）治療薬市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

調査市場
➣ 製品タイプ別
　　◇ カルシウム模倣薬
　　◇ ビタミンD
　　◇ ステロール
　　◇ カリウム結合剤
　　◇ カルシウムベースのリン酸塩結合剤
　　◇ その他の製品
➣ 適応症別
　　◇ 末期腎不全（ESRD）誘発性副甲状腺機能亢進症
　　◇ 末期腎不全（ESRD）誘発性高リン血症
　　◇ 末期腎不全（ESRD）誘発性高カリウム血症
➣ 流通チャネル別
　　◇ 病院薬局
　　◇ オンライン薬局
　　◇ 小売薬局
➣ エンドユーザー別
　　◇ 病院
　　◇ ホームケア
　　◇ 専門クリニック
　　◇ その他のエンドユーザー
調査企業
➣ Pfizer Inc.
➣ AstraZeneca Plc.
➣ Sanofi SA
➣ Astellas Pharma Inc.
➣ Novartis AG
調査国
➣ オーストラリア
➣ ブラジル
➣ 中国
➣ フランス
➣ ドイツ
➣ インド
➣ インドネシア
➣ 日本
➣ ロシア
➣ 韓国
➣ イギリス
➣ アメリカ
調査地域
➣ アジア太平洋地域
➣ 西ヨーロッパ
➣ 東ヨーロッパ
➣ 北アメリカ
➣ 南アメリカ
➣ 中東
➣ アフリカ
調査期間
➣ 5年間の実績データおよび10年間の予測
データ
➣ 市場規模と成長率の関連市場に対する比率
➣ GDP比率
➣ 一人当たりの支出
データセグメント
➣ 国別・地域別の実績および予測データ
➣ 競合企業の市場シェア
➣ 市場セグメント
情報源および参照
➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
提供形態
➣ PDF、Word、Excelデータダッシュボード

レポート詳細

5. End Stage Renal Disease (ESRD) Drug Market Size And Growth
5.1. Global End Stage Renal Disease (ESRD) Drug Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global End Stage Renal Disease (ESRD) Drug Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. End Stage Renal Disease (ESRD) Drug Market Segmentation
6.1. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Calcimimetics
Vitamin D
Sterols
Potassium Binders
Calcium-Based Phosphate Binders
Other Products
6.2. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
End Stage Renal Disease (ESRD) Induced Hyperparathyroidism
End Stage Renal Disease (ESRD) Induced Hyperphosphatemia
End Stage Renal Disease (ESRD) Induced Hyperkalaemia
6.3. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.4. Global End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End Users

7. End Stage Renal Disease (ESRD) Drug Market Regional And Country Analysis
7.1. Global End Stage Renal Disease (ESRD) Drug Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global End Stage Renal Disease (ESRD) Drug Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market
8.1. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China End Stage Renal Disease (ESRD) Drug Market
9.1. China End Stage Renal Disease (ESRD) Drug Market Overview
9.2. China End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India End Stage Renal Disease (ESRD) Drug Market
10.1. India End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan End Stage Renal Disease (ESRD) Drug Market
11.1. Japan End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia End Stage Renal Disease (ESRD) Drug Market
12.1. Australia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia End Stage Renal Disease (ESRD) Drug Market
13.1. Indonesia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea End Stage Renal Disease (ESRD) Drug Market
14.1. South Korea End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe End Stage Renal Disease (ESRD) Drug Market
15.1. Western Europe End Stage Renal Disease (ESRD) Drug Market Overview
15.2. Western Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK End Stage Renal Disease (ESRD) Drug Market
16.1. UK End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany End Stage Renal Disease (ESRD) Drug Market
17.1. Germany End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France End Stage Renal Disease (ESRD) Drug Market
18.1. France End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe End Stage Renal Disease (ESRD) Drug Market
19.1. Eastern Europe End Stage Renal Disease (ESRD) Drug Market Overview
19.2. Eastern Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia End Stage Renal Disease (ESRD) Drug Market
20.1. Russia End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America End Stage Renal Disease (ESRD) Drug Market
21.1. North America End Stage Renal Disease (ESRD) Drug Market Overview
21.2. North America End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA End Stage Renal Disease (ESRD) Drug Market
22.1. USA End Stage Renal Disease (ESRD) Drug Market Overview
22.2. USA End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America End Stage Renal Disease (ESRD) Drug Market
23.1. South America End Stage Renal Disease (ESRD) Drug Market Overview
23.2. South America End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil End Stage Renal Disease (ESRD) Drug Market
24.1. Brazil End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East End Stage Renal Disease (ESRD) Drug Market
25.1. Middle East End Stage Renal Disease (ESRD) Drug Market Overview
25.2. Middle East End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa End Stage Renal Disease (ESRD) Drug Market
26.1. Africa End Stage Renal Disease (ESRD) Drug Market Overview
26.2. Africa End Stage Renal Disease (ESRD) Drug Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa End Stage Renal Disease (ESRD) Drug Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. End Stage Renal Disease (ESRD) Drug Market Competitive Landscape And Company Profiles
27.1. End Stage Renal Disease (ESRD) Drug Market Competitive Landscape
27.2. End Stage Renal Disease (ESRD) Drug Market Company Profiles
27.2.1. Pfizer Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. AstraZeneca Plc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Sanofi SA
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Astellas Pharma Inc.
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Novartis AG
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The End Stage Renal Disease (ESRD) Drug Market

29. End Stage Renal Disease (ESRD) Drug Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000035692

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。